Update on daptomycin: the first approved lipopeptide antibiotic

Author： Lee Su Young   Fan Hong Wei   Kuti Joseph L   Nicolau David P  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.10, 2006-07, pp. : 1381-1397

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The IV antibiotic daptomycin [Cubicin; Oryx Pharmaceuticals] has been approved in Canada.

By  

Inpharma, Vol. 1, Iss. 1608, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Update on linezolid: the first oxazolidinone antibiotic

By Wilcox Mark H  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 13, 2005-10 ,pp. : 2315-2326

Informa Healthcare

Access to resources Recommend Favorite

Biosynthesis and Genetic Engineering of Lipopeptide Antibiotics Related to Daptomycin

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 8, 2008-05 ,pp. : 618-638

Bentham Science Publishers

Access to resources Recommend Favorite

Daptomycin – a novel antibiotic against Gram-positive pathogens

By LaPlante Kerry L   Rybak Michael J  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2321-2331

Informa Healthcare

Access to resources Recommend Favorite

Daptomycin

By Fenton C.   Keating G.M.   Curran M.P.  

Drugs, Vol. 64, Iss. 4, 2004-01 ,pp. : 445-455

Adis International

Access to resources Recommend Favorite